Hadassah

Hadassah Researchers Discover Gene that Compromises Respiratory System

Wednesday, Apr 3 2013

Researchers at the Hadassah University Medical Center have discovered the gene that causes primary ciliary dyskinesia (PCD), a rare condition that compromises the functioning of the cilia, the minute protective hairs in the respiratory system, thereby resulting in repeated lung infections, sinusitis, frequent ear infections, and fertility problems. In about half of the cases, the mutation also causes organs to develop in "mirror image" of one another, so that, for example, the heart develops on the right side of the chest instead of on the left, while the liver grows on the left and the stomach and spleen on the right.

Prof. Eitan Kerem, head of Pediatrics at Hadassah, and Prof. Orly Elpeleg, head of the Department of Genetic and Metabolic Diseases, along with Dr. David Shoseyov and Dr. Malena Cohen discovered the gene by studying five children from two different families who suffer from PCD. Three of the children affected suffer from the transposition of organs. According to medical estimates, the condition occurs in one out of 15,000 births, but the Hadassah researchers believe that PCD is actually more prevalent, though not always diagnosed.

Read more about it in The Jerusalem Post>>

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More